Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDI-NEWS - Based on PLOS ONE. November 2012, Volume 7, Issue 11.
Invasive Meningococcal Disease Epidemiology in Quebec: Changes Demand New Vaccination Strategies against Dominant Strains
October 2013
Significant changes in the epidemiology of invasive meningococcal disease (IMD) have been observed in the province of Quebec during the last two decades. As in many other developed countries, most IMD in Quebec was once caused by serogroup...
PRIORITY PRESS - ID Week - Infectious Diseases Society of America (IDSA)
Update on Antifungal Susceptibility and Management of Special Patient Populations
San Francisco, California / October 2-6, 2013
San Francisco - Attributed to broader use of immunosuppressive therapies, the rising global incidence in invasive fungal infections overall and invasive aspergillosis (IA) specifically threatens a parallel rise in resistant species. This...
PRIORITY PRESS - 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Staying Ahead of the Resistance Curve: Current and Future Strategies for More Effective Infection Control
Denver, Colorado / September 10-13, 2013
Denver - Staying ahead of the resistance curve has never been more challenging in the management of acute and chronic infections. In the past few decades, there has been a remarkable increase in resistance to current antibiotics. As new...
MEDI-NEWS - Based on Lancet 2013;381(9869):825-35.
Invasive Meningococcal Disease in Infants: Immunogenicity and Safety of a Novel Multi-Component Serogroup B Vaccine
Serogroup B is now the dominant cause of invasive meningococcal disease (IMD) in Canada where it disproportionally affects infants. This underscores the importance of having an effective vaccine for this vulnerable age group. A...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Serum Antifungal Concentrations Are Fundamental to Cure of Invasive Aspergillosis
Berlin, Germany / April 27-30, 2013
Berlin - The absence of strategies to ensure adequate antifungal drug levels for the treatment of invasive aspergillosis (IA) and other serious fungal diseases appears to be a major source of poor outcomes, judging from a series of studies...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Recent Developments Promise New Guidelines for Management of C. difficile
Berlin, Germany / April 27-30, 2013
Berlin - Broad initiatives now underway are poised to stem the morbidity and mortality driven by a persistent rise in the incidence of Clostridium difficile infection (CDI). Due to progress in understanding risk factors and an expansion of...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Strategies Evolve to Gain Control of Complicated Gram-Positive Infections
Berlin, Germany / April 27-30, 2013
Berlin - Due to evolving patterns of susceptibility, empiric and first-line therapies for challenging gram-positive infections must be adjusted, according to a series of reports at ECCMID. Alternatives to vancomycin, which is identified as...
PRIORITY PRESS - AMMI Canada - CACMID Annual Conference
New NACI Guidelines for Pneumococcal Disease Prevention in High-Risk Adults
Québec City, Quebec/ April 4-6, 2013
Québec City - Prevention of pneumococcal and other vaccine-preventable diseases is challenging in patients with immune deficiency. Vaccines are less immunogenic in this population. Many patients have not had recommended...
MEDI-NEWS - Update on Quadrivalent Conjugate Meningococcal Vaccines
From the National Advisory Committee on Immunization
March 2013
Ottawa - An update from the National Advisory Committee on Immunization (NACI) on quadrivalent conjugate meningococcal vaccines now includes recommendations for the use of the most recent of these vaccines, MenACWY-CRM197 and provides a...